Joint Pathology
January 18, 2025Task Force Cancer survivorship
January 19, 2025Quality of systemic treatment of breast cancer
Quality management is a key requirement to obtain the best care for our patients. To monitor and to improve the quality of patient care the BSMO created a “Task force for systemic treatment of breast cancer”. A close collaboration with the Belgian Cancer Registry allows calculation and identification of critical and accountable quality indicators.
If you would like to participate to our meetings or have a proposition or remark mail to : Didier.verhoeven@KLINA.be , francois.duhoux@uclouvain.be or to one of the participants.
Participants
Participants
Barbeaux Annelore CHR Verviers
de Azambuja Evandro Bordet Institute , Brussels
Duhoux Francois St Luc, UCL , Brussels
Punie Kevin UZ Gasthuisberg , Leuven
Van Damme Nancy Belgian Cancer Registry
Van Eycken Liesbet Belgian Cancer Registry
van Walle Lien Belgian Cancer Registry
Verhoeven Didier KLINA , Brasschaat
Vuylsteke Peter Clinique Ste Elisabeth, UCL, Namur
Wildiers Hans UZ Gasthuisberg , Leuven
Articles/Abstracts
- Quality management for systemic treatment of breast cancer ,
BJMO 2018 ; 12 (1) : 16-22- D.Verhoeven, F.Duhoux, E de Azambuja, H.Wildiers,
P.Vuylsteke, A.Barbeaux, N.Van Damme, E.Van Eycken
- D.Verhoeven, F.Duhoux, E de Azambuja, H.Wildiers,
- Quality management of systemic breast cancer treatment –
Highlights of BSMO meeting 2018 , BJMO 2018 - Identification and calculation of quality indicators in systemic
treatment in breast cancer . EBCC 2018 , Barcelona- D.Verhoeven,F.Duhoux, E de Azambuja,H.Wildiers,
P.Vuylsteke, A.Barbeaux, N.Van Damme, E.Van Eycken
- D.Verhoeven,F.Duhoux, E de Azambuja,H.Wildiers,
- Systemic treatment in non-metastatic breast cancer in
Belgium: Does age influence intercenter heterogeneity? ENCR
2018 , Copenhagen- L.van Walle, N.Van Damme, H.De Schutter, F.Duhoux, E
de Azambuja, H.Wildiers, P.Vuylsteke, A.Barbeaux,
D.Verhoeven, E.Van Eycken
- L.van Walle, N.Van Damme, H.De Schutter, F.Duhoux, E
Participants_Breast_Cancer_Force_BSMO_2016
Adjuvant endocrine therapy in peri- and premenopausal women with early breast cancer
Systemic chemotherapy regimens in early breast cancer patients: updated recommendations from the BSMO breast cancer task force